## Background: Bcl-2 protein is believed to play a role in neoplasia by inhibiting tumor cell apoptosis. to assess its contribution to gallbladder tumorigenesis and cancer progression, an immunohistochemical study was performed. ## Methods: Fifteen adenomas and 68 adenocarcinomas were immunohisto
โฆ LIBER โฆ
Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma
โ Scribed by Hu, Y-X; Watanabe, H; Ohtsubo, K; Yamaguchi, Y; Ha, A; Motoo, Y; Okai, T; Sawabu, N
- Book ID
- 110002279
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 569 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Association of Bcl-2 protein expression
โ
Tetuo Mikami; Nobuyuki Yanagisawa; Hiroyuki Baba; Morio Koike; Isao Okayasu
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 355 KB
๐ 3 views
Alterations of p53, Bcl-2, and hMSH2 pro
โ
Mahmoud R. Hussein
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 361 KB
Expression of apoptosis-related proteins
โ
T. Nakamura; H. Ide; K. Hayashi; R. Euchi; K. Takasaki
๐
Article
๐
2000
๐
Springer
๐
English
โ 618 KB
Long-term follow-up study on gastric int
โ
Yu Sun; Zhong-Wu Li; Guo-Shuang Feng; Ji-You Li
๐
Article
๐
2009
๐
Chinese Anti-Cancer Association
๐
English
โ 277 KB
Expression of Bcl-2 and p53 protein in r
โ
Yoshinori Nio; Ming Dong; Chikage Iguchi; Kunihiro Yamasawa; Tomoko Toga; Masayu
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 221 KB
## Abstract ## Background and Objectives p53 tumor suppressor gene has a dual role as a trigger of apoptosis and as an initiator of DNA repair. The Bclโ2 can work to protect cells from apoptosis, which is induced by p53 gene. These facts suggest the significant role of these genes in the genesis a
Invasion of the bladder by transitional
โ
Robin T. Vollmer; Peter A. Humphrey; Paul E. Swanson; Mark R. Wick; M'Liss A. Hu
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 125 KB
๐ 2 views
ful in predicting the clinical outcome of transitional cell carcinoma of the bladder, they also create uncertainty. Immunohistochemical staining for p53, MIB-1, epi-